Literature DB >> 1418019

Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event.

E M Westerman1, J M Miles, M Backonja, W R Sundstrom.   

Abstract

OBJECTIVE: There are few reports describing histopathologic changes associated with the antiphospholipid antibody syndrome. We describe a patient with multi-infarct dementia and antiphospholipid antibody syndrome, in whom a brain biopsy was performed.
METHODS: Biopsy material from the left frontal cortex, including meninges, cortex, and underlying subcortical white matter, was investigated. Microscopic examination and special staining were performed.
RESULTS: Microscopic examination showed lumenal occlusion by thrombi, and marked endothelial hyperplasia of small meningeal and cortical arterioles.
CONCLUSION: These findings suggest that the pathogenesis of this cerebral vasculopathy is noninflammatory and is associated with reactive endothelial hyperplasia and thrombosis of small arterioles.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418019     DOI: 10.1002/art.1780350908

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  Antiphospholipid antibodies and the endothelium.

Authors:  B J Hunt; M A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

Review 2.  Association of anticardiolipin antibodies with vascular injury: possible mechanisms.

Authors:  Y S Haviv
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.

Authors:  S S Sun; F Y Liu; J J P Tsai; R F Yen; C H Kao; W S Huang
Journal:  Rheumatol Int       Date:  2003-04-09       Impact factor: 2.631

Review 4.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

5.  Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.

Authors:  L Ziporen; Y Shoenfeld; Y Levy; A D Korczyn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  Autonomic neuropathy-in its many guises-as the initial manifestation of the antiphospholipid syndrome.

Authors:  Jill R Schofield
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

7.  Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

Authors:  Zoe Arvanitakis; Robin L Brey; Jacob H Rand; Julie A Schneider; Sue E Leurgans; Lei Yu; Aron S Buchman; Konstantinos Arfanakis; Debra A Fleischman; Patricia A Boyle; David A Bennett; Steven R Levine
Journal:  Neuroepidemiology       Date:  2012-10-24       Impact factor: 3.282

Review 8.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

9.  Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients.

Authors:  J H Kim; C G Choi; S J Choi; H K Lee; D C Suh
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

10.  Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.

Authors:  Zoe Arvanitakis; Robin L Brey; Jacob H Rand; Julie A Schneider; Ana W Capuano; Lei Yu; Sue E Leurgans; David A Bennett; Steven R Levine
Journal:  Circulation       Date:  2014-10-09       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.